# Intersectional Policy Impact Mapping

Purpose: Explains how standard federal regulatory impact analysis examines distributional effects along single demographic dimensions, systematically missing compounded policy impacts on populations defined by multiple overlapping characteristics, and why OMB Circular A-4 requirements have not closed this gap.

Status: draft

Tags: equity, regulatory impact analysis, OMB Circular A-4, intersectionality, civil rights, OIRA, distributional analysis

Key actors:
- Office of Information and Regulatory Affairs (OIRA, OMB)
- Federal agency program offices (HHS, HUD, USDA, SSA)
- HHS Office of Civil Rights
- Department of Justice Civil Rights Division
- Congressional Budget Office (CBO)
- Academic researchers (intersectionality methods)

Statutes and authorities:
- OMB Circular A-4 (revised September 2023) — Regulatory Analysis standards
- Executive Order 12866 (regulatory review requirements)
- Executive Order 13985, Advancing Racial Equity (January 2021; rescinded January 2025)
- Civil Rights Act of 1964, Title VI (42 U.S.C. § 2000d), Title VII (42 U.S.C. § 2000e)
- Americans with Disabilities Act, 42 U.S.C. § 12101 et seq.

Case studies:
- COVID-19 vaccine distribution equity analysis (single-axis vs. intersectional outcomes)
- EO 13985 agency equity assessments: implementation and rescission
- SNAP eligibility rule changes and compounded impact on disabled elderly rural women

Data sources:
- OMB regulatory review records and OIRA annual report
- Agency regulatory impact analysis archives (regulations.gov)
- GAO reports on equity analysis in federal programs
- HHS Office of Civil Rights complaint data

Related modules:
- 221 Algorithmic Governance Impact on Public Policy
- 228 Intersectional Policy Impact Mapping (cross-reference)
- 069 Administrative Rulemaking

Outline: see `outline.md`

Contributors: add names and links here

How to contribute:

- Add citations to `outline.md` under "Suggested sources"
- Propose visuals in `figures/` and link from this README
